Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Symptom C0032285|pneumonitis
Sentences 20
PubMedID- 23456072 Conclusion: diabetes mellitus is the risk factor of radiation pneumonitis for patients with nonsmall cell lung cancer who receive radiotherapy.
PubMedID- 22842662 Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
PubMedID- 20165822 Correlation of patient-related factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer.
PubMedID- 20193119 Tgf-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
PubMedID- 24161424 Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy.
PubMedID- 21420246 Functional polymorphisms of base excision repair genes xrcc1 and apex1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
PubMedID- 24828665 Radiation pneumonitis in patients with non--small-cell lung cancer treated with erlotinib concurrent with thoracic radiotherapy.
PubMedID- 25545734 Correlations between serum il-6 levels and radiation pneumonitis in lung cancer patients: a meta-analysis.
PubMedID- 26019482 Three polymorphisms in the atm gene – 126713g-to-a, 111g-to-a (rs189037) and g5557a, were found to be associated with increased risk for severe radiation pneumonitis in patients with lung cancer treated with radiotherapy (58, 64).
PubMedID- 22836061 Serum amyloid a as a predictive marker for radiation pneumonitis in lung cancer patients.
PubMedID- 24780874 Genetic variants of the lin28b gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
PubMedID- 23154078 Atm polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
PubMedID- 26382926 In the current study, we compared the risk of radiation pneumonitis in patients with lung cancer who received either helical tomotherapy or static tomotherapy.
PubMedID- 20085905 Objective: to examine the effects of dose-volume factors on the development of radiation pneumonitis in patients with non-small-cell lung cancer who received twice-daily radiotherapy concurrently with carboplatin and paclitaxel chemotherapy.
PubMedID- 24625207 Pre-radiotherapy fdg pet predicts radiation pneumonitis in lung cancer.
PubMedID- 22629334 Of these patients, seven were excluded due to lung cancer with obstructive pneumonitis, and 10 were excluded due to incomplete data for review.
PubMedID- 24454002 Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy.
PubMedID- 21766712 62-year-old man with obstructive pneumonitis due to metastatic lung cancer admitted for surgery.
PubMedID- 22578806 18f-fdg uptake dose-response correlates with radiation pneumonitis in lung cancer patients.
PubMedID- 24920921 Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy.

Page: 1